TAK1 Is a Pivotal Therapeutic Target for Tumor Progression and Bone Destruction in Myeloma
Haematologica - Italy
doi 10.3324/haematol.2019.234476
Full Text
Open PDFAbstract
Available in full text
Categories
Date
April 9, 2020
Authors
Publisher
Ferrata Storti Foundation (Haematologica)